Rudolph M. Navari

Liposome‐encapsulated doxorubicin compared with conventional doxorubicin in a randomized multicenter trial as first‐line therapy of metastatic breast carcinoma

Lyndsay N. Harris, Gerald Batist, Robert J. Belt et al. · Cancer · 2001 · 507 citations · Full text

Olanzapine for the Prevention of Chemotherapy-Induced Nausea and Vomiting

Rudolph M. Navari, Rui Qin, Kathryn J. Ruddy et al. · New England Journal of Medicine · 2016 · 431 citations · Full text

Reduction of Cisplatin-Induced Emesis by a Selective Neurokinin-1–Receptor Antagonist

Rudolph M. Navari, Rick R. Reinhardt, Richard J. Gralla et al. · New England Journal of Medicine · 1999 · 370 citations · Full text

Olanzapine Versus Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting: A Randomized Phase III Trial

Rudolph M. Navari, Sarah E. Gray, Andrew C. Kerr · The Journal of Supportive Oncology · 2011 · 314 citations

The use of olanzapine versus metoclopramide for the treatment of breakthrough chemotherapy-induced nausea and vomiting in patients receiving highly emetogenic chemotherapy

Rudolph M. Navari, Cindy K Nagy, Sarah E. Gray · Supportive Care in Cancer · 2013 · 180 citations

Emetogenic Chemotherapy, Chemotherapy-induced Nausea, Medicine +7